Interstitial magnetic resonance lymphography with gadobutrol in rats: Evaluation of contrast kinetics

Investigative Radiology

Volumn 37, Issue 12, 2002, Pages 655-662

  Fink, Christian ^a   Bock, Michael ^b   Kiessling, Fabian ^a   Delorme, Stefan ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Deutsches Krebsforschungsztr (DKFZ)   (Germany)

Author keywords

Animal studies; Cancer; Metastasis; MR lymphography

Indexed keywords

GADOBUTROL;

ANIMAL EXPERIMENT; ARTICLE; AXILLARY LYMPH NODE; BLOOD; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ILIAC ARTERY; INGUINAL LYMPH NODE; INTERSTITIUM; KIDNEY; LIVER; LYMPH VESSEL; LYMPHOGRAPHY; MALE; MUSCLE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POPLITEAL ARTERY; PRIORITY JOURNAL; RAT; THREE DIMENSIONAL IMAGING; TISSUE DISTRIBUTION;

EID: 0036895866     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200212000-00004     Document Type: Article

References (28)

1. Williams AD, Cousins C, Soutter WP, et al. Detection of pelvic lymph node metastases in gynecologic malignancy: A comparison of CT, MR imaging, and positron emission tomography. AJR 2001;177: 343-348.
2. Curtin HD, Ishwaran H, Mancuso AA, et al. Comparison of CT and MR imaging in staging of neck metastases. Radiology 1998;207: 123-130.
3. Weissleder R, Elizondo G, Josephson L, et al. Experimental lymph node metastases: Enhanced detection with MR lymphography. Radiology 1989;171:835-839.
4. Weissleder R, Elizondo G, Wittenberg J, et al. Ultrasmall superparamagnetic iron oxide: An intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990;175:494-498.
5. Hamm B, Taupitz M, Hussmann P, et al. MR lymphography with iron oxide particles: Dose-response studies and pulse sequence optimization in rabbits. AJR AJR 1992;158:183-190.
6. Tanoura T, Bernas M, Darkazanli A, et al. MR lymphography with iron oxide compound AMI-227: Studies in ferrets with filariasis. AJR AJR 1992;159:875-881.
7. Anzai Y, McLachlan S, Morris M, et al. Dextran-coated superparamagnetic iron oxide, an MR contrast agent for assessing lymph nodes in the head and neck. AJNR Am J Neuroradiol 1994;15:87-94.
8. Pannu HK, Wang KP, Borman TL, et al. MR imaging of mediastinal lymph nodes: Evaluation using a superparamagnetic contrast agent. J Magn Reson Imaging 2000;12:899-904.
9. Rety F, Clement O, Siauve N, et al. MR lymphography using iron oxide nanoparticles in rats: Pharmacokinetics in the lymphatic system after intravenous injection. J Magn Reson Imaging 2000;12:734-739.
10. Bellin MF, Roy C, Kinkel K, et al. Lymph node metastases: Safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles-initial clinical experience. Radiology 1998;207:799-808.
11. Vassallo P, Matei C, Heston WD, et al. Characterization of reactive versus tumor-bearing lymph nodes with interstitial magnetic resonance lymphography in an animal model. Invest Radiol 1995;30:706-711.
12. Harika L, Weissleder R, Poss K, et al. Macromolecular intravenous contrast agent for MR lymphography: Characterization and efficacy studies. Radiology 1996;198:365-370.
13. Harika L, Weissleder R, Poss K, et al. MR lymphography with a lymphotropic T1-type MR contrast agent: Gd-DTPA-PGM. Magn Reson Med 1995;33:88-92.
14. Misselwitz B, Sachse A. Interstitial MR lymphography using Gdcarrying liposomes. Acta Radiol Suppl 1997;412:51-55.
15. Misselwitz B, Platzek J, Raduchel B, et al. Gadofluorine 8 initial experience with a new contrast medium for interstitial MR lymphography. MAGMA 1999;8:190-195.
16. Staatz G, Nolte-Ernsting CC, Adam GB, et al. Interstitial T1-weighted MR lymphography: Lipophilic perfluorinated gadolinium chelates in pigs. Radiology 2001;220:129-134.
17. Misselwitz B, Schmitt-Willich H, Michaelis M, et al. Interstitial magnetic resonance lymphography using a polymeric t contrast agent: Initial experience with Gadomer-17. Invest Radiol 2002;37:146-151.
18. Ruehm SG, Corot C, Debatin JF. Interstitial MR lymphography with a conventional extracellular gadolinium-based agent: Assessment in rabbits. Radiology 2001;218:664-669.
19. Ruehm SG, Schroeder T, Debatin JF. Interstitial MR lymphography with gadoterate meglumine: Initial experience in humans. Radiology 2001;220:816-821.
20. Tombach B, Heindel W. Value of 1.0-M gadolinium chelates: Review of preclinical and clinical data on gadobutrol. Eur Radiol 2002;12: 1550-1556.
21. Goyen M, Lauenstein TC, Herbom CU, et al. 0.5 M Gd chelate (Magnevist) versus 1.0 M Gd chelate (Gadovist): Dose-independent effect on image quality of pelvic three-dimensional MR-angiography. J Magn Reson Imaging 2001;14:602-607.
22. Tombach B, Bremer C, Reimer P, et al. Renal tolerance of a neutral gadolinium chelate (gadobutrol) in patients with chronic renal failure: Results of a randomized study. Radiology 2001;218:651-657.
23. Vogler H, Platzek J, Schuhmann-Giampieri G, et al. Pre-clinical evaluation of gadobutrol: A new, neutral, extracellular contrast agent for magnetic resonance imaging. Eur J Radiol 1995;21:1-10.
24. Staks T, Schuhmann-Giampieri G, Frenzel T, et al. Pharmacokinetics, dose proportionality, and tolerability of gadobutrol after single intravenous injection in healthy volunteers. Invest Radiol 1994;29:709-715.
25. Gomori JM, Grossman RI, Yu-Ip C, et al. NMR relaxation times of blood: Dependence on field strength, oxidation state, and cell integrity. J Comput Assist Tomogr 1987;11:684-690.
26. Wisner ER, Weichert JP, Longino MA, et al. A surface-modified chylomicron remnant-like emulsion for percutaneous computed tomography lymphography: Synthesis and preliminary imaging findings. Invest Radiol 2002;37:232-239.
27. Henze E, Schelbert HR, Collins JD, et al. Lymphoscintigraphy with Tc-99m-labeled dextran. J Nucl Med 1982;23:923-929.
28. Ohtake H, Oikawa M, Syoh T. Right axillary lymph node visualization by bipedal lymphography: A case report. Radiology 1976;121:69-70.